| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cetuximab | complement c1q subcomponent subunit a | biotech | NA | drugbank | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | binder |
| cetuximab | complement c1q subcomponent subunit b | biotech | NA | drugbank | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | binder |
| cetuximab | complement c1q subcomponent subunit c | biotech | NA | drugbank | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | binder |
| cetuximab | epidermal growth factor receptor | biotech | Successful target | TTD , drugbank , DGIDB | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.91 | approved | binder,antibody |
| cetuximab | epidermal growth factor receptor | biotech | Successful target | TTD , drugbank , DGIDB | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.91 | approved | binder,inhibitor |
| cetuximab | epidermal growth factor receptor | biotech | Successful target | TTD , drugbank , DGIDB | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.91 | approved | binder |
| cetuximab | high affinity immunoglobulin gamma fc receptor i | biotech | NA | drugbank | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | binder |
| cetuximab | low affinity immunoglobulin gamma fc region receptor ii-a | biotech | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.69 | approved | binder |
| cetuximab | low affinity immunoglobulin gamma fc region receptor iii-a | biotech | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.56 | approved | binder |
| cetuximab | low affinity immunoglobulin gamma fc region receptor iii-b | biotech | NA | drugbank | Disease[MeSHID:D004194] Colorectal Cancer[MeSHID:D015179] Mutation[MeSHID:D009154] Neoplasm Metastasis[MeSHID:D009362] Squamous cell carcinoma[MeSHID:D002294] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | binder |
| click here to return to the previous page | ||||||||